Alzamend Neuro, Inc.
ALZN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001677077
In the last 90 days, Alzamend Neuro, Inc. insiders filed 1 open-market purchase and 1 sale; 12 institutions reported holding it in 13F filings for Q2 2026, worth $3.26M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Alzamend Neuro, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 24 | 27 | +3 |
| Shares | 6.15M | 6.31M | +159.0K (+2.6%) |
| Value | $3.13M | $1.49M | −$1.64M (−52.3%) |
New holders (6)
Institutions that held Alzamend Neuro, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 27,629 | $6.55K | 0.00% |
| Renaissance Technologies LLC | 21,400 | $5.00K | 0.00% |
| Foundations Investment Advisors, LLC | 20,000 | $4.74K | 0.00% |
| XTX Topco Ltd | 12,974 | $3.08K | 0.00% |
| FMR LLC | 268 | $64 | 0.00% |
| JPMorgan Chase & Co | 49 | $12 | 0.00% |
Sold out (3)
Institutions that held Alzamend Neuro, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Virtu Financial LLC | 21,309 | $11.0K |
| Cubist Systematic Strategies, LLC | 10,503 | $5.36K |
| Group One Trading, L.P. | 5,062 | $2.58K |